| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A National Cancer Institute of Canada Clinical Trials Group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer
|
Knowling, M.
|
|
|
12 |
7 |
p. 919-922
|
artikel
|
| 2 |
A National Cancer Institute of Canada Clinical Trials Group phase IIstudy of eniluracil (776C85) and oral 5-fluorouracil in patients with advancedsquamous cell head and neck cancer
|
M. Knowling
|
|
2001
|
12 |
7 |
p. 919-922
4 p.
|
artikel
|
| 3 |
Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia
|
Dazzi, H.
|
|
|
12 |
7 |
p. 963-966
|
artikel
|
| 4 |
Anthracycline-induced acute cardiotoxicity in adults treated forleukaemia
|
H. Dazzi
|
|
2001
|
12 |
7 |
p. 963-966
4 p.
|
artikel
|
| 5 |
A phase I–II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer
|
Hussain, S.A.
|
|
|
12 |
7 |
p. 929-935
|
artikel
|
| 6 |
A phase III study of synchronous chemoradiotherapy for poorprognosis locally advanced bladder cancer
|
S. A. Hussain
|
|
2001
|
12 |
7 |
p. 929-935
7 p.
|
artikel
|
| 7 |
A randomized trial of four cycles of adjuvant AC (adriamycin +cyclophosphamide) ± two cycles of EP (etoposide + cisplatin) innode positive patients with breast cancer
|
F. Içli
|
|
2001
|
12 |
7 |
p. 1011-1013
3 p.
|
artikel
|
| 8 |
A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) ± two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancer* * Preliminary results of this study were presented at the 35th Annual Meeting of ASCO in 1999.
|
Içli, F.
|
|
|
12 |
7 |
p. 1011-1013
|
artikel
|
| 9 |
Awards, appointments
|
Mellstedt, Håkan
|
|
|
12 |
7 |
p. 879
|
artikel
|
| 10 |
Book review
|
Fizazi, K.
|
|
|
12 |
7 |
p. 1025
|
artikel
|
| 11 |
Book review
|
Aebi, S.
|
|
|
12 |
7 |
p. 1026
|
artikel
|
| 12 |
Cancer genetics in oncology practice
|
Olopade, O.I.
|
|
|
12 |
7 |
p. 895-908
|
artikel
|
| 13 |
Cancer genetics in oncology practice
|
O. I. Olopade
|
|
2001
|
12 |
7 |
p. 895-908
14 p.
|
artikel
|
| 14 |
Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features
|
Shannon, C.
|
|
|
12 |
7 |
p. 947-952
|
artikel
|
| 15 |
Carboplatin and gemcitabine in metastatic transitional cell carcinoma ofthe urothelium: Effective treatment of patients with poor prognosticfeatures
|
C. Shannon
|
|
2001
|
12 |
7 |
p. 947-952
6 p.
|
artikel
|
| 16 |
Carcinocythemia as the single extension of breast cancer: Report of a case and review of the literature
|
Seronie-Vivien, S.
|
|
|
12 |
7 |
p. 1019-1022
|
artikel
|
| 17 |
Carcinocythemia as the single extension of breast cancer:Report of a case and review of the literature
|
S. Seronie-Vivien
|
|
2001
|
12 |
7 |
p. 1019-1022
4 p.
|
artikel
|
| 18 |
Chemotherapy in cervical cancer: Is cisplatin alone still the standard of care?
|
Tattersall, M.H.N.
|
|
|
12 |
7 |
p. 883
|
artikel
|
| 19 |
Chemotherapy in cervical cancer: Is cisplatin alone still the standardof care?
|
M. H. N. Tattersall
|
|
2001
|
12 |
7 |
p. 883-883
1 p.
|
artikel
|
| 20 |
Combined modality treatment for locally advanced squamous-cell carcinoma of the oropharynx in a woman with Bloom’s syndrome: A case report and review of the literature
|
Ma, B.
|
|
|
12 |
7 |
p. 1015-1017
|
artikel
|
| 21 |
Combined modality treatment for locally advanced squamous-cell carcinomaof the oropharynx in a woman with Blooms syndrome: A case report andreview of the literature
|
B. Ma
|
|
2001
|
12 |
7 |
p. 1015-1017
3 p.
|
artikel
|
| 22 |
Contents of the next issue
|
|
|
|
12 |
7 |
p. iv
|
artikel
|
| 23 |
Copyright
|
|
|
|
12 |
7 |
p. ii
|
artikel
|
| 24 |
Editorial Board
|
|
|
|
12 |
7 |
p. iii
|
artikel
|
| 25 |
Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study
|
Quoix, E.
|
|
|
12 |
7 |
p. 957-962
|
artikel
|
| 26 |
Etoposide phosphate with carboplatin in the treatment of elderly patientswith small-cell lung cancer: A phase II study
|
E. Quoix
|
|
2001
|
12 |
7 |
p. 957-962
6 p.
|
artikel
|
| 27 |
Get set, ready, go and walk briskly: Obesity and cancer go together
|
|
|
|
12 |
7 |
p. 877-878
|
artikel
|
| 28 |
Health research
|
|
|
|
12 |
7 |
p. 878
|
artikel
|
| 29 |
Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease
|
Raderer, M.
|
|
|
12 |
7 |
p. 937-939
|
artikel
|
| 30 |
Impaired response of gastric MALT-lymphoma to Helicobacter pylorieradication in patients with autoimmune disease
|
M. Raderer
|
|
2001
|
12 |
7 |
p. 937-939
3 p.
|
artikel
|
| 31 |
In this issue
|
|
|
|
12 |
7 |
p. iv
|
artikel
|
| 32 |
Intra-arterial hepatic chemotherapy (IAHC) for liver metastases from colorectal cancer: Need of guidelines for catheter positioning, port management, and anti-coagulant therapy
|
Fiorentini, G.
|
|
|
12 |
7 |
p. 1023-1024
|
artikel
|
| 33 |
Intra-arterial hepatic chemotherapy (IAHC) for liver metastases fromcolorectal cancer: Need of guidelines for catheter positioning, portmanagement, and anti-coagulant therapy
|
G. Fiorentini
|
|
2001
|
12 |
7 |
p. 1023-1023
1 p.
|
artikel
|
| 34 |
J. M. S. Bartlett (ed.): Ovarian Cancer Methods andProtocols
|
S. Aebi
|
|
2001
|
12 |
7 |
p. 1026-1026
1 p.
|
artikel
|
| 35 |
Leanness and squamous cell oesophageal cancer
|
Gallus, S.
|
|
|
12 |
7 |
p. 975-979
|
artikel
|
| 36 |
Leanness and squamous cell oesophageal cancer
|
S. Gallus
|
|
2001
|
12 |
7 |
p. 975-979
5 p.
|
artikel
|
| 37 |
M. I. Resnick & I. M. Thompson (eds): Advanced Therapy ofProstate Disease
|
K. Fizazi
|
|
2001
|
12 |
7 |
p. 1025-1025
1 p.
|
artikel
|
| 38 |
New centre in Italy for breast cancer treatment and research
|
|
|
|
12 |
7 |
p. 877
|
artikel
|
| 39 |
Obituary
|
|
|
|
12 |
7 |
p. 879
|
artikel
|
| 40 |
Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia
|
Novak, U.
|
|
|
12 |
7 |
p. 981-986
|
artikel
|
| 41 |
Overexpression of the p73 gene is a novel finding in high-risk B-cellchronic lymphocytic leukemia
|
U. Novak
|
|
2001
|
12 |
7 |
p. 981-986
6 p.
|
artikel
|
| 42 |
Paclitaxel plus organoplatins: Still the gold standard in advanced ovarian cancer?
|
Boccardo, F.
|
|
|
12 |
7 |
p. 1023-1024
|
artikel
|
| 43 |
Paclitaxel plus organoplatins: Still the gold standard in advancedovarian cancer?
|
F. Boccardo
|
|
2001
|
12 |
7 |
p. 1023-1024
2 p.
|
artikel
|
| 44 |
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma
|
Younes, A.
|
|
|
12 |
7 |
p. 923-927
|
artikel
|
| 45 |
Paclitaxel plus topotecan treatment for patients with relapsed orrefractory aggressive non-Hodgkins lymphoma
|
A. Younes
|
|
2001
|
12 |
7 |
p. 923-927
5 p.
|
artikel
|
| 46 |
Perhaps not everyone knows that…
|
|
|
|
12 |
7 |
p. 880-882
|
artikel
|
| 47 |
Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer
|
Campone, M.
|
|
|
12 |
7 |
p. 909-918
|
artikel
|
| 48 |
Phase I dose-finding and pharmacokinetic study of docetaxel andvinorelbine as first-line chemotherapy for metastatic breast cancer
|
M. Campone
|
|
2001
|
12 |
7 |
p. 909-918
10 p.
|
artikel
|
| 49 |
Phobias
|
|
|
|
12 |
7 |
p. 878
|
artikel
|
| 50 |
Prevention of mucositis in bone marrow transplantation: A double blind randomised controlled trial of sucralfate
|
Castagna, L.
|
|
|
12 |
7 |
p. 953-955
|
artikel
|
| 51 |
Prevention of mucositis in bone marrow transplantation: A double blindrandomised controlled trial of sucralfate
|
L. Castagna
|
|
2001
|
12 |
7 |
p. 953-955
3 p.
|
artikel
|
| 52 |
Primary non-Hodgkin’s lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses
|
Emile, J.-F.
|
|
|
12 |
7 |
p. 1005-1010
|
artikel
|
| 53 |
Primary non-Hodgkins lymphomas of the liver with nodular anddiffuse infiltration patterns have different prognoses
|
J.-F. Emile
|
|
2001
|
12 |
7 |
p. 1005-1010
6 p.
|
artikel
|
| 54 |
Proteome and Genome: Where is the new (financial) frontier?
|
|
|
|
12 |
7 |
p. 878
|
artikel
|
| 55 |
Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial
|
Veronesi, U.
|
|
|
12 |
7 |
p. 997-1003
|
artikel
|
| 56 |
Radiotherapy after breast-conserving surgery in small breast carcinoma:Long-term results of a randomized trial
|
U. Veronesi
|
|
2001
|
12 |
7 |
p. 997-1003
7 p.
|
artikel
|
| 57 |
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC Gynecological Cancer Cooperative Group study
|
Vermorken, J.B.
|
|
|
12 |
7 |
p. 967-974
|
artikel
|
| 58 |
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, andcisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cellcarcinoma of the uterine cervix: An EORTC Gynecological Cancer CooperativeGroup study
|
J. B. Vermorken
|
|
2001
|
12 |
7 |
p. 967-974
8 p.
|
artikel
|
| 59 |
Royalty implicated in a scandal again?
|
|
|
|
12 |
7 |
p. 877
|
artikel
|
| 60 |
Royalty implicated in a scandal again?New centre in Italy for breast cancer treatment and research.Get set, ready, go and walk briskly: Obesity and cancer go together.Proteome and Genome: Where is the new (financial) frontier?Phobias.Health research.Obituary.Awards, appointments.Perhaps not everyone knows that...
|
|
|
2001
|
12 |
7 |
p. 877-882
6 p.
|
artikel
|
| 61 |
Surgical management of hepatic metastases from colorectal malignancies
|
Malafosse, R.
|
|
|
12 |
7 |
p. 887-894
|
artikel
|
| 62 |
Surgical management of hepatic metastases from colorectalmalignancies
|
R. Malafosse
|
|
2001
|
12 |
7 |
p. 887-894
8 p.
|
artikel
|
| 63 |
Table of Contents
|
|
|
|
12 |
7 |
p. i-ii
|
artikel
|
| 64 |
Thalidomide and dexamethasone combination for refractory multiple myeloma
|
Dimopoulos, M.A.
|
|
|
12 |
7 |
p. 991-995
|
artikel
|
| 65 |
Thalidomide and dexamethasone combination for refractorymultiple myeloma
|
M. A. Dimopoulos
|
|
2001
|
12 |
7 |
p. 991-995
5 p.
|
artikel
|
| 66 |
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
|
Bertolini, F.
|
|
|
12 |
7 |
p. 987-990
|
artikel
|
| 67 |
Thalidomide in multiple myeloma, myelodysplastic syndromes andhistiocytosis. Analysis of clinical results and of surrogate angiogenesismarkers
|
F. Bertolini
|
|
2001
|
12 |
7 |
p. 987-990
4 p.
|
artikel
|
| 68 |
The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study
|
Waldherr, C.
|
|
|
12 |
7 |
p. 941-945
|
artikel
|
| 69 |
The clinical value of[90Y-DOTA]-D-Phe1-Tyr3-octreotide(90Y-DOTATOC) in the treatment of neuroendocrine tumours: Aclinical phase II study
|
C. Waldherr
|
|
2001
|
12 |
7 |
p. 941-945
5 p.
|
artikel
|
| 70 |
The revitalization of thalidomide
|
Thomas, D.A.
|
|
|
12 |
7 |
p. 885-886
|
artikel
|
| 71 |
The revitalization of thalidomide
|
D. A. Thomas
|
|
2001
|
12 |
7 |
p. 885-886
2 p.
|
artikel
|
Tijdschrift beschrijving